Events
These events and webinars are intended for veterinary professionals only.
Zennovation in Sedation: Rethinking What is Possible #23044
Speaker:
Jennifer Kasten, DVM
In this educational presentation, we will discuss sedation in dogs. The foundation will be set by reviewing the basic physiology behind commonly used sedatives in dogs. We will discuss the most commonly used sedatives and reversal agents, and introduce the novel sedative Zenalpha (medetomidine and vatinoxan hydrochlorides).
07:00 PM EST
1 RACE-Approved Credit
RACE# 27059-918761
Wednesday, February 1, 2023, 19:00 - 20:00
location_on Dinner Meeting, Lancaster, PA
Zennovation in Sedation: Rethinking What is Possible #23043
Speaker:
Jennifer Kasten, DVM
In this educational presentation, we will discuss sedation in dogs. The foundation will be set by reviewing the basic physiology behind commonly used sedatives in dogs. We will discuss the most commonly used sedatives and reversal agents, and introduce the novel sedative Zenalpha (medetomidine and vatinoxan hydrochlorides).
07:00 PM EST
1 RACE-Approved Credit
RACE# 27059-918761
Monday, February 6, 2023, 19:00 - 20:00
location_on Dinner Meeting, Mount Vernon, OH
Management of the Broodmare #23008
Speaker:
Hadley Whiting, DVM
The presenter will discuss the routine care the mare requires throughout the year. Topics will include preparing the mare through anestrus to managing her cycle to conception. The medications and tools used in the breeding shed will be discussed along with maintenance considerations for the pregnant mare from conception to foaling.
07:00 PM EST
RACE# 27059-898393
1 RACE-Approved Credit Hour
Tuesday, February 7, 2023, 19:00 - 20:00
location_on Virtual Meeting
Zennovation in Sedation: Rethinking What is Possible #23042
Speaker:
Jim Lowe, DVM
In this educational presentation, we will discuss sedation in dogs. The foundation will be set by reviewing the basic physiology behind commonly used sedatives in dogs. We will discuss the most commonly used sedatives and reversal agents, and introduce the novel sedative Zenalpha (medetomidine and vatinoxan hydrochlorides).
07:00 PM CST
1 RACE-Approved Credit
RACE# 27059-918761
Tuesday, February 7, 2023, 19:00 - 20:00
location_on Dinner Meeting, Clarksville, TN
Zennovation in Sedation: Rethinking What is Possible #23009
Speaker:
Jim Lowe, DVM
In this educational presentation, we will discuss sedation in dogs. The foundation will be set by reviewing the basic physiology behind commonly used sedatives in dogs. We will discuss the most commonly used sedatives and reversal agents, and introduce the novel sedative Zenalpha (medetomidine and vatinoxan hydrochlorides).
07:00 PM EST
1 RACE-Approved Credit
RACE# 27059-918761
Thursday, February 9, 2023, 19:00 - 20:00
location_on Virtual Meeting
Update on Managing Canine Hyperadrenocorticism #23010
Speaker:
Kathy Engler, DVM, DABVP
Canine Hyperadrenocorticism (Cushing’s Disease) can be a challenging yet rewarding disease to manage. This presentation will review all aspects of Cushing’s: basic pathophysiology, clinical signs, diagnostics, differentiating tests, treatment and monitoring. A series of cases to increase understanding of managing Cushing’s patients will be presented and the final section highlights ways to enhance owner compliance.
07:00 PM EST
1.5 RACE-Approved Credits
RACE# 27059-869593
Wednesday, February 15, 2023, 19:00 - 20:00
location_on Virtual Meeting
Zennovation in Sedation: Rethinking What is Possible #23059
Speaker:
Mike LaRosh, DVM
In this educational presentation, we will discuss sedation in dogs. The foundation will be set by reviewing the basic physiology behind commonly used sedatives in dogs. We will discuss the most commonly used sedatives and reversal agents, and introduce the novel sedative Zenalpha (medetomidine and vatinoxan hydrochlorides).
07:00 PM MST
1 RACE-Approved Credit
RACE# 27059-918761
Wednesday, February 15, 2023, 19:00 - 20:00
location_on Dinner Meeting, Denver, CO
Zennovation in Sedation: Rethinking What is Possible #23052
Speaker:
Jennifer Kasten, DVM
In this educational presentation, we will discuss sedation in dogs. The foundation will be set by reviewing the basic physiology behind commonly used sedatives in dogs. We will discuss the most commonly used sedatives and reversal agents, and introduce the novel sedative Zenalpha (medetomidine and vatinoxan hydrochlorides).
07:00 PM EST
1 RACE-Approved Credit
RACE# 27059-918761
Thursday, February 16, 2023, 19:00 - 20:00
location_on Dinner Meeting, Pembroke Pines, FL
Zennovation in Sedation: Rethinking What is Possible #23060
Speaker:
Mike LaRosh, DVM
In this educational presentation, we will discuss sedation in dogs. The foundation will be set by reviewing the basic physiology behind commonly used sedatives in dogs. We will discuss the most commonly used sedatives and reversal agents, and introduce the novel sedative Zenalpha (medetomidine and vatinoxan hydrochlorides).
07:00 PM MST
1 RACE-Approved Credit
RACE# 27059-918761
Thursday, February 16, 2023, 19:00 - 20:00
location_on Dinner Meeting, Lakewood, CO
Update on Managing Canine Hyperadrenocorticism #23011
Speaker:
Timothy Smaha, DVM
Canine Hyperadrenocorticism (Cushing’s Disease) can be a challenging yet rewarding disease to manage. This presentation will review all aspects of Cushing’s: basic pathophysiology, clinical signs, diagnostics, differentiating tests, treatment and monitoring. A series of cases to increase understanding of managing Cushing’s patients will be presented and the final section highlights ways to enhance owner compliance.
10:00 PM EST
1.5 RACE-Approved Credits
RACE# 27059-869593
Thursday, February 16, 2023, 22:00 - 23:30
location_on Virtual Meeting
Verdinexor: A Novel Oral Therapy for Canine Lymphoma #23064
Speaker:
Kathy Engler, DVM, DABVP
This lecture will discuss the novel class of drugs called SINE inhibitors, with emphasis on verdinexor (Laverdia-CA1). We will review SINE mechanism of action, along with a thorough review of the data leading to a reasonable expectation of efficacy and FDA conditional approval of Laverdia-CA1. We will also look at where this new oral option fits into specialty and primary care practice therapies as consideration for future use. The attendee will learn how to properly dose and safely dispense verdinexor as well as how to monitor the lymphoma patient on verdinexor, including how to address any potential adverse events.
7:00 PM PST
1 RACE-Approved Credit
RACE# 27059-900255
Tuesday, February 21, 2023, 19:00 - 20:00
location_on Dinner Meeting, Seattle, WA
Zennovation in Sedation: Rethinking What is Possible #23012
Speaker:
Kathy Engler, DVM, DABVP
In this educational presentation, we will discuss sedation in dogs. The foundation will be set by reviewing the basic physiology behind commonly used sedatives in dogs. We will discuss the most commonly used sedatives and reversal agents, and introduce the novel sedative Zenalpha (medetomidine and vatinoxan hydrochlorides).
10:00 PM EST
1 RACE-Approved Credit
RACE# 27059-918761
Tuesday, February 21, 2023, 22:00 - 23:00
location_on Virtual Meeting
Verdinexor: A Novel Oral Therapy for Canine Lymphoma #23063
Speaker:
Kathy Engler, DVM, DABVP
This lecture will discuss the novel class of drugs called SINE inhibitors, with emphasis on verdinexor (Laverdia-CA1). We will review SINE mechanism of action, along with a thorough review of the data leading to a reasonable expectation of efficacy and FDA conditional approval of Laverdia-CA1. We will also look at where this new oral option fits into specialty and primary care practice therapies as consideration for future use. The attendee will learn how to properly dose and safely dispense verdinexor as well as how to monitor the lymphoma patient on verdinexor, including how to address any potential adverse events.
7:00 PM PST
1 RACE-Approved Credit
RACE# 27059-900255
Wednesday, February 22, 2023, 19:00 - 20:00
location_on Dinner Meeting, Woodinville, WA
Zennovation in Sedation: Rethinking What is Possible #23077
Speaker:
Elizabeth Mongol-Gunter, VMD
In this educational presentation, we will discuss sedation in dogs. The foundation will be set by reviewing the basic physiology behind commonly used sedatives in dogs. We will discuss the most commonly used sedatives and reversal agents, and introduce the novel sedative Zenalpha (medetomidine and vatinoxan hydrochlorides).
07:00 PM EST
1 RACE-Approved Credit
RACE# 27059-918761
Wednesday, February 22, 2023, 19:00 - 20:00
location_on Dinner Meeting, Fredericksburg, VA
Zennovation in Sedation: Rethinking What is Possible #23080
Speaker:
Gregory Long, DVM
In this educational presentation, we will discuss sedation in dogs. The foundation will be set by reviewing the basic physiology behind commonly used sedatives in dogs. We will discuss the most commonly used sedatives and reversal agents, and introduce the novel sedative Zenalpha (medetomidine and vatinoxan hydrochlorides).
07:00 PM EST
1 RACE-Approved Credit
RACE# 27059-918761
Wednesday, February 22, 2023, 19:00 - 20:00
location_on Dinner Meeting, Clearwater, FL
Verdinexor: A Novel Oral Therapy for Canine Lymphoma & Zennovation in Sedation: Rethinking What is Possible #23065
Speaker:
Kathy Engler, DVM, DABVP
Zennovation in Sedation: Rethinking What is Possible
In this educational presentation, we will discuss sedation in dogs. The foundation will be set by reviewing the basic physiology behind commonly used sedatives in dogs. We will discuss the most commonly used sedatives and reversal agents, and introduce the novel sedative Zenalpha (medetomidine and vatinoxan hydrochlorides).
Verdinexor: A Novel Oral Therapy for Canine Lymphoma
This lecture will discuss the novel class of drugs called SINE inhibitors, with emphasis on verdinexor (Laverdia-CA1). We will review SINE mechanism of action, along with a thorough review of the data leading to a reasonable expectation of efficacy and FDA conditional approval of Laverdia-CA1. We will also look at where this new oral option fits into specialty and primary care practice therapies as consideration for future use. The attendee will learn how to properly dose and safely dispense verdinexor as well as how to monitor the lymphoma patient on verdinexor, including how to address any potential adverse events.
7:00 PM PST
2 RACE-Approved Credit
Thursday, February 23, 2023, 19:00 - 20:00
location_on Dinner Meeting, Seattle, WA
Verdinexor: A Novel Oral Therapy for Canine Lymphoma #23013
Speaker:
Pam Mitchell, MS, DVM
This lecture will discuss the novel class of drugs called SINE inhibitors, with emphasis on verdinexor (Laverdia-CA1). We will review SINE mechanism of action, along with a thorough review of the data leading to a reasonable expectation of efficacy and FDA conditional approval of Laverdia-CA1. We will also look at where this new oral option fits into specialty and primary care practice therapies as consideration for future use. The attendee will learn how to properly dose and safely dispense verdinexor as well as how to monitor the lymphoma patient on verdinexor, including how to address any potential adverse events.
02:00 PM EST
1 RACE-Approved Credit
RACE# 27059-900255
Tuesday, February 28, 2023, 14:00 - 15:00
location_on Virtual Meeting
Zennovation in Sedation: Rethinking What is Possible #23014
Speaker:
Jennifer Kasten, DVM
In this educational presentation, we will discuss sedation in dogs. The foundation will be set by reviewing the basic physiology behind commonly used sedatives in dogs. We will discuss the most commonly used sedatives and reversal agents, and introduce the novel sedative Zenalpha (medetomidine and vatinoxan hydrochlorides).
02:00 PM EST
1 RACE-Approved Credit
RACE# 27059-918761
Thursday, March 2, 2023, 14:00 - 15:00
location_on Virtual Meeting
Update on Managing Canine Hyperadrenocorticism #23015
Speaker:
Bridget Fitzpatrick, DVM
Canine Hyperadrenocorticism (Cushing’s Disease) can be a challenging yet rewarding disease to manage. This presentation will review all aspects of Cushing’s: basic pathophysiology, clinical signs, diagnostics, differentiating tests, treatment and monitoring. A series of cases to increase understanding of managing Cushing’s patients will be presented and the final section highlights ways to enhance owner compliance.
12:00 PM EST
1.5 RACE-Approved Credit
RACE# 27059-869593
Tuesday, March 14, 2023, 12:00 - 13:30
location_on Virtual Meeting
Zennovation in Sedation: Rethinking What is Possible #23071
Speaker:
Kathy Engler, DVM, DABVP
In this educational presentation, we will discuss sedation in dogs. The foundation will be set by reviewing the basic physiology behind commonly used sedatives in dogs. We will discuss the most commonly used sedatives and reversal agents, and introduce the novel sedative Zenalpha (medetomidine and vatinoxan hydrochlorides).
07:00 PM Central
1 RACE-Approved Credit
RACE# 27059-918761
Tuesday, March 14, 2023, 19:00 - 20:00
location_on Dinner Meeting, Schaumburg, IL
Zennovation in Sedation: Rethinking What is Possible #23076
Speaker:
Gregory Long, DVM
In this educational presentation, we will discuss sedation in dogs. The foundation will be set by reviewing the basic physiology behind commonly used sedatives in dogs. We will discuss the most commonly used sedatives and reversal agents, and introduce the novel sedative Zenalpha (medetomidine and vatinoxan hydrochlorides).
07:00 PM EST
1 RACE-Approved Credit
RACE# 27059-918761
Tuesday, March 14, 2023, 19:00 - 20:00
location_on Dinner Meeting, Rock Hill, SC
Zennovation in Sedation: Rethinking What is Possible and Verdinexor: A Novel Oral Therapy for Canine Lymphoma #23072
Speaker:
Kathy Engler, DVM, DABVP
In this educational presentation, we will discuss sedation in dogs. The foundation will be set by reviewing the basic physiology behind commonly used sedatives in dogs. We will discuss the most commonly used sedatives and reversal agents, and introduce the novel sedative Zenalpha (medetomidine and vatinoxan hydrochlorides).
Part 2: This lecture will discuss the novel class of drugs called SINE inhibitors, with emphasis on verdinexor (Laverdia-CA1). We will review SINE mechanism of action, along with a thorough review of the data leading to a reasonable expectation of efficacy and FDA conditional approval of Laverdia-CA1. We will also look at where this new oral option fits into specialty and primary care practice therapies as consideration for future use. The attendee will learn how to properly dose and safely dispense verdinexor as well as how to monitor the lymphoma patient on verdinexor, including how to address any potential adverse events.
1:00 PM Central
2 RACE-Approved Credit
Wednesday, March 15, 2023, 13:00 - 15:00
location_on Dinner Meeting, Brook, IL
Verdinexor: A Novel Oral Therapy for Canine Lymphoma #23016
Speaker:
Jim Lowe, DVM
This lecture will discuss the novel class of drugs called SINE inhibitors, with emphasis on verdinexor (Laverdia-CA1). We will review SINE mechanism of action, along with a thorough review of the data leading to a reasonable expectation of efficacy and FDA conditional approval of Laverdia-CA1. We will also look at where this new oral option fits into specialty and primary care practice therapies as consideration for future use. The attendee will learn how to properly dose and safely dispense verdinexor as well as how to monitor the lymphoma patient on verdinexor, including how to address any potential adverse events.
07:00 PM EST
1 RACE-Approved Credit
RACE# 27059-900255
Wednesday, March 15, 2023, 19:00 - 20:00
location_on Virtual Meeting
Zennovation in Sedation: Rethinking What is Possible #23088
Speaker:
Gregory Long, DVM
In this educational presentation, we will discuss sedation in dogs. The foundation will be set by reviewing the basic physiology behind commonly used sedatives in dogs. We will discuss the most commonly used sedatives and reversal agents, and introduce the novel sedative Zenalpha (medetomidine and vatinoxan hydrochlorides).
07:00 PM EDT
1 RACE-Approved Credit
RACE# 27059-918761
Wednesday, March 15, 2023, 19:00 - 20:00
location_on Dinner Meeting, Asheville, NC
Zennovation in Sedation: Rethinking What is Possible #23066
Speaker:
Kathy Engler, DVM, DABVP
In this educational presentation, we will discuss sedation in dogs. The foundation will be set by reviewing the basic physiology behind commonly used sedatives in dogs. We will discuss the most commonly used sedatives and reversal agents, and introduce the novel sedative Zenalpha (medetomidine and vatinoxan hydrochlorides).
07:00 PM Central
1 RACE-Approved Credit
RACE# 27059-918761
Thursday, March 16, 2023, 19:00 - 20:00
location_on Dinner Meeting, Orland Park, IL
Zennovation in Sedation: Rethinking What is Possible #23069
Speaker:
James Sturzione, DVM, MBS
In this educational presentation, we will discuss sedation in dogs. The foundation will be set by reviewing the basic physiology behind commonly used sedatives in dogs. We will discuss the most commonly used sedatives and reversal agents, and introduce the novel sedative Zenalpha (medetomidine and vatinoxan hydrochlorides).
06:30 PM EST
1 RACE-Approved Credit
RACE# 27059-918761
Monday, March 20, 2023, 18:30 - 19:00
location_on Dinner Meeting, Burlington, VT
Zennovation in Sedation: Rethinking What is Possible #23068
Speaker:
James Sturzione, DVM, MBS
In this educational presentation, we will discuss sedation in dogs. The foundation will be set by reviewing the basic physiology behind commonly used sedatives in dogs. We will discuss the most commonly used sedatives and reversal agents, and introduce the novel sedative Zenalpha (medetomidine and vatinoxan hydrochlorides).
06:00 PM EDT
1 RACE-Approved Credit
RACE# 27059-918761
Tuesday, March 21, 2023, 18:00 - 19:00
location_on Dinner Meeting, Rutland, VT
Zennovation in Sedation: Rethinking What is Possible #23092
Speaker:
Kathy Engler, DVM, DABVP
In this educational presentation, we will discuss sedation in dogs. The foundation will be set by reviewing the basic physiology behind commonly used sedatives in dogs. We will discuss the most commonly used sedatives and reversal agents, and introduce the novel sedative Zenalpha (medetomidine and vatinoxan hydrochlorides).
07:00 PM CDT
1 RACE-Approved Credit
RACE# 27059-918761
Wednesday, March 22, 2023, 19:00 - 20:00
location_on Dinner Meeting, Lawrence, KS
Verdinexor: A Novel Oral Therapy for Canine Lymphoma #23093
Speaker:
Kathy Engler, DVM, DABVP
This lecture will discuss the novel class of drugs called SINE inhibitors, with emphasis on verdinexor (Laverdia-CA1). We will review SINE mechanism of action, along with a thorough review of the data leading to a reasonable expectation of efficacy and FDA conditional approval of Laverdia-CA1. We will also look at where this new oral option fits into specialty and primary care practice therapies as consideration for future use. The attendee will learn how to properly dose and safely dispense verdinexor as well as how to monitor the lymphoma patient on verdinexor, including how to address any potential adverse events.
07:00 PM CDT
1 RACE-Approved Credit
RACE# 27059-900255
Thursday, March 23, 2023, 19:00 - 20:00
location_on Dinner Meeting, Lawrence, KS
Canine Otitis Externa: Diagnosis, Management, and Success #23017
Speaker:
Gregory Long, DVM
Canine otitis externa is one of the most frequently encountered conditions in small animal veterinary practice. This presentation explores the causes of canine otitis externa including the predisposing, primary and perpetuating factors, the importance of otic cytology, and the essential treatment modalities to help ensure clinical resolution. The development of a long-term maintenance cleaning and allergy management plan will also be discussed.
10:00 PM EST
Thursday, March 23, 2023, 22:00 - 23:00
location_on Virtual Meeting
Zennovation in Sedation: Rethinking What is Possible #23073
Speaker:
Jennifer Kasten, DVM
In this educational presentation, we will discuss sedation in dogs. The foundation will be set by reviewing the basic physiology behind commonly used sedatives in dogs. We will discuss the most commonly used sedatives and reversal agents, and introduce the novel sedative Zenalpha (medetomidine and vatinoxan hydrochlorides).
07:00 PM EST
1 RACE-Approved Credit
RACE# 27059-918761
Tuesday, March 28, 2023, 19:00 - 20:00
location_on Dinner Meeting, Prospect, KY
Maximizing Topical Therapy in Companion Animal Practice #23018
Speaker:
Julie Kluxdal, DVM
With dermatologic conditions making up a large volume of the caseload in companion animal medicine and with antimicrobial resistance on the rise, topical therapies need to play a bigger role in dermatologic therapy. This presentation will discuss why topical therapies are helpful and how cytology helps guide topical product choice. The most common active ingredients in topical products for companion animals will be highlighted including their mechanism of action and suggested use. By having a complete understanding of active ingredients, veterinarians will be better equipped to make a topical product selection. Compliance strategies will be discussed to help ensure that what a veterinarian prescribes actually gets used.
12:00 PM EST
RACE# 27059-906349
1 RACE-Approved Credit Hour
Thursday, March 30, 2023, 12:00 - 13:00
location_on Virtual Meeting
Verdinexor: A Novel Oral Therapy for Canine Lymphoma #23019
Speaker:
Gregory Long, DVM
This lecture will discuss the novel class of drugs called SINE inhibitors, with emphasis on verdinexor (Laverdia-CA1). We will review SINE mechanism of action, along with a thorough review of the data leading to a reasonable expectation of efficacy and FDA conditional approval of Laverdia-CA1. We will also look at where this new oral option fits into specialty and primary care practice therapies as consideration for future use. The attendee will learn how to properly dose and safely dispense verdinexor as well as how to monitor the lymphoma patient on verdinexor, including how to address any potential adverse events.
07:00 PM EST
1 RACE-Approved Credit
RACE# 27059-900255
Wednesday, April 5, 2023, 19:00 - 20:00
location_on Virtual Meeting
Zennovation in Sedation: Rethinking What is Possible #23020
Speaker:
Elizabeth Mongol-Gunter, VMD
In this educational presentation, we will discuss sedation in dogs. The foundation will be set by reviewing the basic physiology behind commonly used sedatives in dogs. We will discuss the most commonly used sedatives and reversal agents, and introduce the novel sedative Zenalpha (medetomidine and vatinoxan hydrochlorides).
07:00 PM EST
1 RACE-Approved Credit
RACE# 27059-918761
Wednesday, April 12, 2023, 19:00 - 20:00
location_on Virtual Meeting
Canine Otitis Externa: Diagnosis, Management, and Success #23021
Speaker:
Bridget Fitzpatrick, DVM
Canine otitis externa is one of the most frequently encountered conditions in small animal veterinary practice. This presentation explores the causes of canine otitis externa including the predisposing, primary and perpetuating factors, the importance of otic cytology, and the essential treatment modalities to help ensure clinical resolution. The development of a long-term maintenance cleaning and allergy management plan will also be discussed.
12:00 PM EST
Tuesday, April 18, 2023, 12:00 - 13:00
location_on Virtual Meeting
Verdinexor: A Novel Oral Therapy for Canine Lymphoma #23081
Speaker:
Julie Kluxdal, DVM
This lecture will discuss the novel class of drugs called SINE inhibitors, with emphasis on verdinexor (Laverdia-CA1). We will review SINE mechanism of action, along with a thorough review of the data leading to a reasonable expectation of efficacy and FDA conditional approval of Laverdia-CA1. We will also look at where this new oral option fits into specialty and primary care practice therapies as consideration for future use. The attendee will learn how to properly dose and safely dispense verdinexor as well as how to monitor the lymphoma patient on verdinexor, including how to address any potential adverse events.
07:00 PM PDT
1 RACE-Approved Credit
RACE# 27059-900255
Tuesday, April 25, 2023, 19:00 - 20:00
location_on Dinner Meeting, Chico, CA
Maximizing Topical Therapy in Companion Animal Practice #23022
Speaker:
Mike LaRosh, DVM
With dermatologic conditions making up a large volume of the caseload in companion animal medicine and with antimicrobial resistance on the rise, topical therapies need to play a bigger role in dermatologic therapy. This presentation will discuss why topical therapies are helpful and how cytology helps guide topical product choice. The most common active ingredients in topical products for companion animals will be highlighted including their mechanism of action and suggested use. By having a complete understanding of active ingredients, veterinarians will be better equipped to make a topical product selection. Compliance strategies will be discussed to help ensure that what a veterinarian prescribes actually gets used.
10:00 PM EST
RACE# 27059-906349
1 RACE-Approved Credit Hour
Tuesday, April 25, 2023, 20:00 - 21:00
location_on Virtual Meeting
Verdinexor: A Novel Oral Therapy for Canine Lymphoma #23082
Speaker:
Julie Kluxdal, DVM
This lecture will discuss the novel class of drugs called SINE inhibitors, with emphasis on verdinexor (Laverdia-CA1). We will review SINE mechanism of action, along with a thorough review of the data leading to a reasonable expectation of efficacy and FDA conditional approval of Laverdia-CA1. We will also look at where this new oral option fits into specialty and primary care practice therapies as consideration for future use. The attendee will learn how to properly dose and safely dispense verdinexor as well as how to monitor the lymphoma patient on verdinexor, including how to address any potential adverse events.
07:00 PM PDT
1 RACE-Approved Credit
RACE# 27059-900255
Wednesday, April 26, 2023, 19:00 - 20:00
location_on Dinner Meeting, Chico, CA
Verdinexor: A Novel Oral Therapy for Canine Lymphoma #23023
Speaker:
Jim Lowe, DVM
This lecture will discuss the novel class of drugs called SINE inhibitors, with emphasis on verdinexor (Laverdia-CA1). We will review SINE mechanism of action, along with a thorough review of the data leading to a reasonable expectation of efficacy and FDA conditional approval of Laverdia-CA1. We will also look at where this new oral option fits into specialty and primary care practice therapies as consideration for future use. The attendee will learn how to properly dose and safely dispense verdinexor as well as how to monitor the lymphoma patient on verdinexor, including how to address any potential adverse events.
02:00 PM EST
1 RACE-Approved Credit
RACE# 27059-900255
Tuesday, May 2, 2023, 14:00 - 15:00
location_on Virtual Meeting
Equine Regenerative Therapy - Autologous Blood Products #23024
Speaker:
Brett Robinson, DVM
The presenter reviews equine regenerative therapy. Focus areas include basic principles of regenerative medicine, FDA regulations, and types of autologous blood products. The types of medical devices necessary for processing autologous blood products including centrifugation, filtration, and incubation are all discussed. Additionally, a meta-analysis of current research with regards to platelet rich plasma (PRP), autologous conditioned serum (ACS), autologous protein solutions (APS), and alpha 2 macroglobulin will be analyzed.
RACE# 27059-924918
1 RACE-Approved Credit Hour
07:00 PM
Wednesday, May 3, 2023, 19:00 - 20:00
location_on Virtual Meeting
Canine Otitis Externa: Diagnosis, Management, and Success #23025
Speaker:
Timothy Smaha, DVM
Canine otitis externa is one of the most frequently encountered conditions in small animal veterinary practice. This presentation explores the causes of canine otitis externa including the predisposing, primary and perpetuating factors, the importance of otic cytology, and the essential treatment modalities to help ensure clinical resolution. The development of a long-term maintenance cleaning and allergy management plan will also be discussed.
07:00 PM EST
Wednesday, May 10, 2023, 19:00 - 20:00
location_on Virtual Meeting
Zennovation in Sedation: Rethinking What is Possible #23026
Speaker:
Jennifer Kasten, DVM
In this educational presentation, we will discuss sedation in dogs. The foundation will be set by reviewing the basic physiology behind commonly used sedatives in dogs. We will discuss the most commonly used sedatives and reversal agents, and introduce the novel sedative Zenalpha (medetomidine and vatinoxan hydrochlorides).
12:00 PM EST
1 RACE-Approved Credit
RACE# 27059-918761
Tuesday, May 16, 2023, 12:00 - 13:00
location_on Virtual Meeting
Update on Managing Canine Hyperadrenocorticism #23027
Speaker:
Jennifer Kasten, DVM
Canine Hyperadrenocorticism (Cushing’s Disease) can be a challenging yet rewarding disease to manage. This presentation will review all aspects of Cushing’s: basic pathophysiology, clinical signs, diagnostics, differentiating tests, treatment and monitoring. A series of cases to increase understanding of managing Cushing’s patients will be presented and the final section highlights ways to enhance owner compliance.
02:00 PM EST
1.5 RACE-Approved Credits
RACE# 27059-869593
Wednesday, May 17, 2023, 14:00 - 15:00
location_on Virtual Meeting
Maximizing Topical Therapy in Companion Animal Practice #23028
Speaker:
James Sturzione, DVM, MBS
With dermatologic conditions making up a large volume of the caseload in companion animal medicine and with antimicrobial resistance on the rise, topical therapies need to play a bigger role in dermatologic therapy. This presentation will discuss why topical therapies are helpful and how cytology helps guide topical product choice. The most common active ingredients in topical products for companion animals will be highlighted including their mechanism of action and suggested use. By having a complete understanding of active ingredients, veterinarians will be better equipped to make a topical product selection. Compliance strategies will be discussed to help ensure that what a veterinarian prescribes actually gets used.
02:00 PM EST
RACE# 27059-906349
1 RACE-Approved Credit Hour
Thursday, May 25, 2023, 14:00 - 15:00
location_on Virtual Meeting
Verdinexor: A Novel Oral Therapy for Canine Lymphoma #23029
Speaker:
James Sturzione, DVM, MBS
This lecture will discuss the novel class of drugs called SINE inhibitors, with emphasis on verdinexor (Laverdia-CA1). We will review SINE mechanism of action, along with a thorough review of the data leading to a reasonable expectation of efficacy and FDA conditional approval of Laverdia-CA1. We will also look at where this new oral option fits into specialty and primary care practice therapies as consideration for future use. The attendee will learn how to properly dose and safely dispense verdinexor as well as how to monitor the lymphoma patient on verdinexor, including how to address any potential adverse events.
07:00 PM EST
1 RACE-Approved Credit
RACE# 27059-900255
Thursday, June 1, 2023, 19:00 - 20:00
location_on Virtual Meeting
It's About Perfusion #23030
Speaker:
Mike LaRosh, DVM
This presentation will review the components of an appropriate fluid plan including why fluids are useful, which fluid, and how to calculate the correct volume and rate. In addition, monitoring guidelines to ensure the fluid plan is adequate and appropriate will be discussed. Participants will also learn about the endothelial glycocalyx and its important role in maintaining normal vascular function.
RACE# 27059-743915
1 RACE-Approved Credit Hour
10 PM EST
Tuesday, June 6, 2023, 22:00 - 23:00
location_on Virtual Meeting
Canine Otitis Externa: Diagnosis, Management, and Success #23031
Speaker:
Elizabeth Mongol-Gunter, VMD
Canine otitis externa is one of the most frequently encountered conditions in small animal veterinary practice. This presentation explores the causes of canine otitis externa including the predisposing, primary and perpetuating factors, the importance of otic cytology, and the essential treatment modalities to help ensure clinical resolution. The development of a long-term maintenance cleaning and allergy management plan will also be discussed.
02:00 PM EST
RACE# 27059-963682
1 RACE-Approved Credit Hour
Tuesday, June 13, 2023, 14:00 - 15:00
location_on Virtual Meeting
Maximizing Topical Therapy in Companion Animal Practice #23032
Speaker:
Mike LaRosh, DVM
With dermatologic conditions making up a large volume of the caseload in companion animal medicine and with antimicrobial resistance on the rise, topical therapies need to play a bigger role in dermatologic therapy. This presentation will discuss why topical therapies are helpful and how cytology helps guide topical product choice. The most common active ingredients in topical products for companion animals will be highlighted including their mechanism of action and suggested use. By having a complete understanding of active ingredients, veterinarians will be better equipped to make a topical product selection. Compliance strategies will be discussed to help ensure that what a veterinarian prescribes actually gets used.
07:00 PM EST
RACE# 27059-906349
1 RACE-Approved Credit Hour
Wednesday, June 21, 2023, 19:00 - 20:00
location_on Virtual Meeting
Zennovation in Sedation: Rethinking What is Possible #23033
Speaker:
Julie Kluxdal, DVM
In this educational presentation, we will discuss sedation in dogs. The foundation will be set by reviewing the basic physiology behind commonly used sedatives in dogs. We will discuss the most commonly used sedatives and reversal agents, and introduce the novel sedative Zenalpha (medetomidine and vatinoxan hydrochlorides).
07:00 PM EST
1 RACE-Approved Credit
RACE# 27059-918761
Thursday, June 29, 2023, 19:00 - 20:00
location_on Virtual Meeting